IP Library › Granted Patent US 12,458,328
Granted Patent B2
US 12,458,328 · App. 18/186,114 · Granted Nov 4, 2025

Methods for delivery of bodily fluids onto a fibrous substrate

Inventors: Ben Moga (Soquel, CA); Ben Casavant (Seattle, WA); Erwin Berthier (Seattle, WA)
Assignee: Tasso, Inc.
A61B10/0045A61B5/150022A61B5/150068A61B5/150251A61B5/150343A61B5/150366A61B10/0038A61B10/0096B01L3/502B01L3/5023A61B2503/42B01L2200/18B01L2300/069B01L2300/0816B01L2400/0406
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,458,328
App. No.
18/186,114
Granted
Nov 4, 2025
Kind
B2
Abstract

The disclosed apparatus, systems and methods relate to devices, systems and methods for the collection of bodily fluids. The collector can make use of microfluidic networks connected to collection sites on the skin of a subject to gather and shuttle blood into a removable cartridge. The collected fluid is supplied to substrate for drying, storage and transport.

Claims (16)

1 . A system for collecting blood from a subject, the system comprising:

a blood collection device sized and shaped to be positioned against skin of the subject, wherein the blood collection device is actuatable to puncture the skin of the subject and to collect blood from the subject;

a collection cartridge having a first end portion and a second end portion opposite the first portion, wherein the collection cartridge defines a lumen extending in a direction at least partially between the first and second end portions, and wherein the first end portion includes a connector sized and shaped to be releasably coupled to the blood collection device to create a hermetic seal with the blood collection device and to receive a flow of the blood from the blood collection device in the direction at least partially between the first and second end portions; and

multiple porous substrates defining a modular network within the lumen between the first and second end portions, and wherein the substrates are spaced apart from one another in the direction at least partially between the first and second end portions and out of contact with one another along the lumen such that the substrates sequentially receive the flow of blood and store at least a portion of the blood.

2 . The system of claim 1 wherein at least one of the multiple porous substrates further comprises at least one reagent.

3 . The system of claim 1 wherein the multiple porous substrates comprise at least a first substrate and a second substrate positioned linearly within the lumen between the first and second end portions.

4 . The system of claim 3 wherein the multiple porous substrates further comprise at least a third substrate positioned linearly with the first substrate and the second substrate within the lumen between the first and second end portions.

5 . The system of claim 4 wherein the second substrate is further comprised of at least a first reagent, and the third substrate is further comprised of at least a second reagent.

6 . The system of claim 4 wherein the second substrate is further comprised of paper.

7 . The system of claim 4 wherein the multiple porous substrates further comprise a fourth substrate adjacent to the first substrate.

8 . The system of claim 7 wherein the fourth substrate is configured to receive excess blood from the first substrate.

9 . The system of claim 1 further comprising:

an open channel within the lumen, wherein the open channel extends in the direction at least partially between the first and second end portions, wherein the open channel is in fluidic communication with one or more of the substrates, and wherein the one or more substrates are configured to receive the flow of blood via the open channel.

10 . The system of claim 9 wherein the multiple substrates include a first substrate and a second substrate, and wherein the second substrate is configured to receive the flow of blood via the open channel after the first substrate has reached saturation.

11 . The system of claim 1 wherein the connector is sized and shaped to be releasably coupled to the blood collection device to create a hermetic seal with the blood collection device when the blood collection device is actuated to puncture the skin of the subject.

12 . The system of claim 1 , wherein each of the substrates is configured to separate plasma from the stored potion of the blood therein.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2023
From: MOGA, BEN; CASAVANT, BEN; BERTHIER, ERWIN
To: TASSO, INC.
Reel/Frame 065015/0159 →
Continuity (4)
Continuation 17186483 · Feb 26, 2021
Continuation 15711746 · Sep 21, 2017
Provisional Application 62397751 · Sep 21, 2016
Related Publication 20240090880A1 · Mar 21, 2024
References Cited (33)
US 6226378B1 · Quattrocchi · 2001 [cited by applicant]
US 11622750B2 · Moga et al. · 2023 [cited by applicant]
US 20010021536A1 · Lee · 2001 [cited by applicant]
US 20040197226A1 · Ray et al. · 2004 [cited by applicant]
US 20050288605A1 · Pellegrino et al. · 2005 [cited by applicant]
US 20080243159A1 · Schraga · 2008 [cited by applicant]
US 20090287237A1 · Nicholls · 2009 [cited by applicant]
US 20110124130A1 · Wagner et al. · 2011 [cited by applicant]
US 20130157381A1 · Pang · 2013 [cited by examiner]
US 20130211289A1 · Moga et al. · 2013 [cited by applicant]
US 20140208836A1 · Murphy · 2014 [cited by examiner]
US 20150080929A1 · Yi et al. · 2015 [cited by applicant]
US 20150209068A1 · Booker et al. · 2015 [cited by applicant]
US 20150305916A1 · Hanuka et al. · 2015 [cited by applicant]
US 20160331292A1 · Leskowich et al. · 2016 [cited by applicant]
US 20210177383A1 · Moga et al. · 2021 [cited by applicant]
CN 102576031 · 2012 [cited by applicant]
CN 104582571A · 2015 [cited by applicant]
CN 104968269A · 2015 [cited by applicant]
EP 1389443 · 2004 [cited by applicant]
EP 2439540 · 2012 [cited by applicant]
EP 2484448 · 2012 [cited by applicant]
EP 2863798 · 2015 [cited by applicant]
WO WO2013191552 · 2013 [cited by applicant]
WO WO2014088606 · 2014 [cited by applicant]
WO WO2016074046 · 2016 [cited by applicant]
WO WO2021076846 · 2021 [cited by applicant]
WO WO2021188594 · 2021 [cited by applicant]
Extended European Search Report received for EP Application No. 17853907.8; Applicant: Tasso, Inc, Date of Mailing: Apr. 9, 2020, 8 pages. [cited by applicant]
International Preliminary Report on Patentability received for PCT Application No. PCT/US2017/052754; Applicant: Tasso, Inc., Date of Mailing: Apr. 4, 2019, 7 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Application No. PCT/US17/52754; Applicant: Tasso, Inc., Date of Mailing: Nov. 29, 2017, 12 pages. [cited by applicant]
Chinese First Office Action issued for Chinese Application No. 201780072026.9; Applicant: Tasso, Inc., Date of Mailing: Mar. 26, 2021, 7 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Application No. PCT/US20/55916; Applicant: Tasso, Inc., Date of Mailing: Mar. 18, 2021, 11 pages. [cited by applicant]